Ubiquitin-Mediated Regulation of RIPK1 Kinase Activity Independent of IKK and MK2.
Loading...
Embargo End Date
ICR Authors
Authors
Annibaldi, A
Wicky John, S
Vanden Berghe, T
Swatek, KN
Ruan, J
Liccardi, G
Bianchi, K
Elliott, PR
Choi, SM
Van Coillie, S
Bertin, J
Wu, H
Komander, D
Vandenabeele, P
Silke, J
Meier, P
Wicky John, S
Vanden Berghe, T
Swatek, KN
Ruan, J
Liccardi, G
Bianchi, K
Elliott, PR
Choi, SM
Van Coillie, S
Bertin, J
Wu, H
Komander, D
Vandenabeele, P
Silke, J
Meier, P
Document Type
Journal Article
Date
2018-02-15
Date Accepted
2018-01-19
Abstract
Tumor necrosis factor (TNF) can drive inflammation, cell survival, and death. While ubiquitylation-, phosphorylation-, and nuclear factor κB (NF-κB)-dependent checkpoints suppress the cytotoxic potential of TNF, it remains unclear whether ubiquitylation can directly repress TNF-induced death. Here, we show that ubiquitylation regulates RIPK1's cytotoxic potential not only via activation of downstream kinases and NF-kB transcriptional responses, but also by directly repressing RIPK1 kinase activity via ubiquitin-dependent inactivation. We find that the ubiquitin-associated (UBA) domain of cellular inhibitor of apoptosis (cIAP)1 is required for optimal ubiquitin-lysine occupancy and K48 ubiquitylation of RIPK1. Independently of IKK and MK2, cIAP1-mediated and UBA-assisted ubiquitylation suppresses RIPK1 kinase auto-activation and, in addition, marks it for proteasomal degradation. In the absence of a functional UBA domain of cIAP1, more active RIPK1 kinase accumulates in response to TNF, causing RIPK1 kinase-mediated cell death and systemic inflammatory response syndrome. These results reveal a direct role for cIAP-mediated ubiquitylation in controlling RIPK1 kinase activity and preventing TNF-mediated cytotoxicity.
Citation
Molecular cell, 2018, 69 (4), pp. 566 - 580.e5
Source Title
Publisher
CELL PRESS
ISSN
1097-2765
eISSN
1097-4164
Collections
Research Team
Cell Death and Immunity